Treatment and outcomes of melanoma in acral location in korean patients

Yonsei Medical Journal

Volumn 51, Issue 4, 2010, Pages 562-568

  Roh, Mi Ryung ^a   Kim, Jihyun ^a   Chung, Kee Yang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Acral locations; Melanoma; Prognosis; Treatment

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACK; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; ULCER; UNIVARIATE ANALYSIS; FOOT; HAND; MIDDLE AGED; MORTALITY; PATHOLOGY; SKIN TUMOR;

ADULT; AGED; FEMALE; FOOT; HAND; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 77956200587     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.4.562     Document Type: Article

References (41)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Dooley TP. Recent advances in cutaneous melanoma oncogenesis research. Oncol Res 1994;6:1-9.
3. Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999;41:945-949.
4. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-1678.
5. Luk NM, Ho LC, Choi CL, Wong KH, Yu KH, Yeung WK. Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese. Clin Exp Dermatol 2004; 29:600-604.
6. Ishihara K, Saida T, Yamamoto A, Japanese Skin Cancer Society Prognosis and Statistical Investigation Committee. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 2001;6:109-116.
7. Lee MW, Koh JK, Kwon KS, Kim NI, Kim SW, Kim SN, et al. Clinical and histopathological study of cutaneous melanoma in Korea. Korean J Dermatol 2003;41:43-47.
8. Moon SE, Cho KH, Hwang JH, Kim JA, Youn JI. A statistical study of cutaneous malignant tumors. Korean J Dermatol 1998; 36:7-15.
9. Hemmings DE, Johnson DS, Tominaga GT, Wong JH. Cutaneous melanoma in a multiethnic population: is this a different disease? Arch Surg 2004;139:968-972.
10. Balch CM, Cascinelli N. The new melanoma staging system. Tumori 2001;87:S64-6S8.
11. Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006;166:1907-1914.
12. Jang KA, Kim JH, Choi JH, Sung KJ, Moon KC, Koh JK. A Clinico-histopathological study of malignant melanoma. Korean J Dermatol 2000;38:1435-1443.
13. Park KD, Lee SJ, Lee WJ, Kim DW, Chung HY, Cho BC. Clinicopathological features of cutaneous malignant melanoma. Korean J Dermatol 2007;45:149-158.
14. Lee DH, Kim YC, Cho SH, Lee MG. Clinicopathologic analysis of malignant melanoma. Korean J Dermatol 2002;40:914-923.
15. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-2424.
16. Boyle P, Maisonneuve P, Doré JF. Epidemiology of malignant melanoma. Br Med Bull 1995;51:523-547.
17. Tsai T, Vu C, Henson DE. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res 2005;15:213-217.
18. Morton DL, Davtyan DG, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-3743.
19. Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995;75:2484-2491.
20. Vollmer RT. Malignant melanoma. A multivariate analysis of prognostic factors. Pathol Annu 1989;24 Pt 1:383-407.
21. Breslow A. Tumor thickness, level of invasion and node dissec-tion in stage I cutaneous melanoma. Ann Surg 1975;182:572-575.
22. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma. Prognostic variables in nodepositive patients. Ann Surg 1990;212:125-131.
23. Hu S, Ma F, Collado-Mesa F, Kirsner RS. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 2004; 140:819-824.
24. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
25. Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC Jr, Sober AJ. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987;258:3146-154.
26. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-933.
27. Elwood JM. Melanoma and sun exposure. Semin Oncol 1996; 23:650-666.
28. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006;55:741-760.
29. McCredie M, Coates MS, Ford JM. Cancer incidence in migrants to New South Wales from England, Wales, Scotland and Ireland. Br J Cancer 1990;62:992-995.
30. Cooke KR, Fraser J. Migration and death from malignant melanoma. Int J Cancer 1985;36:175-178.
31. Titus-Ernstoff L. An overview of the epidemiology of cutaneous melanoma. Clin Plast Surg 2000;27:305-316, vii.
32. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75:667-673.
33. Stevens NG, Liff JM, Weiss NS. Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 1990;45:691-693.
34. Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol 2000;143:275-280.
35. Wells KE, Reintgen DS, Cruse CW. The current management and prognosis of acral lentiginous melanoma. Ann Plast Surg 1992;28:100-103.
36. Tseng JF, Tanabe KK, Gadd MA, Cosimi AB, Malt RA, Haluska FG, et al. Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg 1997;225:544-550.
37. Daly JM, Berlin R, Urmacher C. Subungual melanoma: a 25-year review of cases. J Surg Oncol 1987;35:107-112.
38. Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H. "Functional" surgery in subungual melanoma. Dermatol Surg 2003;29:366-374.
39. Franke W, Neumann NJ, Ruzicka T, Schulte KW. Plantar malignant melanoma--a challenge for early recognition. Melanoma Res 2000;10:571-576.
40. Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 1994;179:279-284.
41. Kato T, Suetake T, Sugiyama Y, Tanita Y, Kumasaka K, Takematsu H, et al. Improvement in survival rate of patients with acral melanoma observed in the past 22 years in Sendai, Japan. Clin Exp Dermatol 1993;18:107-110.